AXCELIS TECHNOLOGIES INC (ACLS)

US0545402085 - Common Stock

112.49  -1.19 (-1.05%)

After market: 112.49 0 (0%)

Fundamental Rating

7

Taking everything into account, ACLS scores 7 out of 10 in our fundamental rating. ACLS was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACLS is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make ACLS suitable for growth and quality investing!



8

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 19.14%, ACLS belongs to the top of the industry, outperforming 93.46% of the companies in the same industry.
ACLS's Return On Equity of 27.74% is amongst the best of the industry. ACLS outperforms 87.85% of its industry peers.
ACLS's Return On Invested Capital of 23.38% is amongst the best of the industry. ACLS outperforms 93.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACLS is significantly above the industry average of 10.93%.
The last Return On Invested Capital (23.38%) for ACLS is above the 3 year average (22.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.14%
ROE 27.74%
ROIC 23.38%
ROA(3y)16.79%
ROA(5y)12.3%
ROE(3y)24.74%
ROE(5y)17.73%
ROIC(3y)22.37%
ROIC(5y)16.23%

1.3 Margins

ACLS has a better Profit Margin (22.16%) than 79.44% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
ACLS has a better Operating Margin (24.00%) than 79.44% of its industry peers.
In the last couple of years the Operating Margin of ACLS has grown nicely.
ACLS has a Gross Margin (44.59%) which is comparable to the rest of the industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24%
PM (TTM) 22.16%
GM 44.59%
OM growth 3Y24.37%
OM growth 5Y11.64%
PM growth 3Y27.39%
PM growth 5Y16%
GM growth 3Y1.27%
GM growth 5Y1.38%

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACLS is creating value.
Compared to 1 year ago, ACLS has less shares outstanding
Compared to 5 years ago, ACLS has more shares outstanding
The debt/assets ratio for ACLS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 8.17 indicates that ACLS is not in any danger for bankruptcy at the moment.
ACLS has a Altman-Z score of 8.17. This is in the better half of the industry: ACLS outperforms 76.64% of its industry peers.
ACLS has a debt to FCF ratio of 0.31. This is a very positive value and a sign of high solvency as it would only need 0.31 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.31, ACLS belongs to the best of the industry, outperforming 80.37% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that ACLS is not too dependend on debt financing.
ACLS has a better Debt to Equity ratio (0.05) than 61.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.31
Altman-Z 8.17
ROIC/WACC1.86
WACC12.6%

2.3 Liquidity

A Current Ratio of 4.00 indicates that ACLS has no problem at all paying its short term obligations.
The Current ratio of ACLS (4.00) is better than 63.55% of its industry peers.
ACLS has a Quick Ratio of 2.87. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.87, ACLS perfoms like the industry average, outperforming 58.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 2.87

7

3. Growth

3.1 Past

ACLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.51%, which is quite impressive.
The Earnings Per Share has been growing by 40.65% on average over the past years. This is a very strong growth
The Revenue has grown by 16.33% in the past year. This is quite good.
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 20.63% on average per year.
EPS 1Y (TTM)33.51%
EPS 3Y76.12%
EPS 5Y40.65%
EPS Q2Q%9.79%
Revenue 1Y (TTM)16.33%
Revenue growth 3Y33.56%
Revenue growth 5Y20.63%
Sales Q2Q%-0.65%

3.2 Future

ACLS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.43% yearly.
ACLS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.27% yearly.
EPS Next Y-13.06%
EPS Next 2Y5.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.7%
Revenue Next 2Y4.75%
Revenue Next 3Y10.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.86, the valuation of ACLS can be described as correct.
Based on the Price/Earnings ratio, ACLS is valued cheaper than 88.78% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACLS to the average of the S&P500 Index (28.05), we can say ACLS is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.62 indicates a correct valuation of ACLS.
Based on the Price/Forward Earnings ratio, ACLS is valued cheaply inside the industry as 88.78% of the companies are valued more expensively.
ACLS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.07.
Industry RankSector Rank
PE 14.86
Fwd PE 13.62

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 91.59% of the companies listed in the same industry.
83.18% of the companies in the same industry are more expensive than ACLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.34
EV/EBITDA 9.89

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y5.43%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (5/31/2024, 7:21:38 PM)

After market: 112.49 0 (0%)

112.49

-1.19 (-1.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.66B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.86
Fwd PE 13.62
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 19.14%
ROE 27.74%
ROCE
ROIC
ROICexc
ROICexgc
OM 24%
PM (TTM) 22.16%
GM 44.59%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4
Quick Ratio 2.87
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)33.51%
EPS 3Y76.12%
EPS 5Y
EPS Q2Q%
EPS Next Y-13.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.33%
Revenue growth 3Y33.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y